Strengthening Drug Quality Assurance Systems in Mali: Workshop to Establish an Operational Pharmacovigilance Program and Training in Drug Registration, Good Laboratory Practices, and Basic Pharmacopeial Testing

The trip aimed to establish an operational pharmacovigilance program and provide training in drug registration, good laboratory practices, and basic pharmacopeial testing. The USP DQI team met with key stakeholders, including the Direction de la Pharmacie et du Médicament (DPM), the Laboratoire National de la Santé (LNS), and USAID/Mali, to discuss the planned activities and planned activities. The team provided training to the national laboratory staff on good laboratory practices and compendial testing using High Performance Liquid Chromatography (HPLC) and Dissolution. They also facilitated training for drug registration officers from DPM on drug registration and drug import verification using the World Health Organization's (WHO) SIAMED software. Additionally, the team facilitated a micro-planning workshop to establish an operational pharmacovigilance program. The USP DQI team met with Dr. Sixte Zigirumugabé and Mr. Bob de Wolfe at USAID/Mali to brief them on the planned activities. They also met with Dr. Haoua Doumbia, Director of DPM, to discuss the planned activities and planned activities. Dr. Doumbia assured the USP DQI team of his support and willingness to provide any necessary assistance. The USP DQI team also met with Dr. Amara Traoré, who chaired the pharmacovigilance workshop, and Pr. Koumaré and Dr. Konaté, who facilitated the organization of the laboratory training. The team expressed their gratitude to the participants in the laboratory training and the drug registration training for their contributions and contributions. The USP DQI team also expressed their appreciation to Dr. Daouda Touré for coordinating the activities and to Mr. Anthony Boni and Ms. Veer Coignez at USAID Washington for their support. The team also thanked the DQI administrative staff and editors for their logistical arrangements and for editing the trip report. The USP DQI Trip Report highlights the importance of strengthening drug quality assurance systems in Mali. The report emphasizes the need for a national drug control laboratory, drug registration processes, and pharmacovigilance programs. The report also highlights the USP DQI's role in providing training and technical assistance to the Malian authorities. The report provides an overview of the activities conducted during the trip, including the laboratory training, drug registration training, and pharmacovigilance workshop. The report also highlights the key stakeholders involved in the trip, including the DPM, LNS, and USAID/Mali. The USP DQI Trip Report is a valuable resource for understanding the challenges and opportunities in strengthening drug quality assurance systems in Mali. The report provides insights into the USP DQI's approach to providing technical assistance and technical assistance to the Malian authorities. The report highlights the importance of collaboration between the USP DQI and the Malian authorities in strengthening drug quality assurance systems. The report also emphasizes the need for a national drug control laboratory, drug registration processes, and pharmacovigilance programs.